Journal of Spectroscopy

Journal of Spectroscopy / 2009 / Article

Open Access

Volume 23 |Article ID 418698 | 6 pages |

Raman spectroscopic study of bioactive silica-based glasses: The role of the alkali/alkali earth ratio on the Non-Bridging Oxygen/Bridging Oxygen (NBO/BO) ratio


Raman spectra of bioactive glasses of the Na2O–K2O–MgO–CaO–B2O3–P2O5–SiO2 to be used in bone reconstruction systems have been collected from samples with three different concentrations of alkali and alkali earth elements. Compositions were chosen with a constant total amount of modifiers and formers, with only minor changes among the formers. The ratio of Non-Bridging Oxygens to Bridging Oxygens (NBO/BO) has been obtained from the Raman spectra and reported as a function of the alkali/alkali earth ratio, showing a linear increase. Dissolution tests indicate also a linear dependence of the amount of Na+, K+ and Ca++ ions leached in water on the alkali/alkali earth ratio. Consequently a calibration plot correlating the NBO/BO ratio with the amount of Na+, K+ and Ca++ ions leached in water has been obtained, thus demonstrating the sensitivity of the method, given that the changes from one glass composition to the other are of the order of some points in percentage among the glass modifiers.

Copyright © 2009 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

349 Views | 1023 Downloads | 18 Citations
 PDF  Download Citation  Citation
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.